QC
AXSM icon

Quent Capital’s Axsome Therapeutics AXSM Stock Holding History

Quent Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,213
Closed -$96.5K – 1361
2023
Q4 		$96.5K Hold
1,213
– – 0.01% 458
2023
Q3 		$84.8K Hold
1,213
– – 0.01% 451
2023
Q2 		$87.2K Hold
1,213
– – 0.01% 454
2023
Q1 		$74.8K Hold
1,213
– – 0.01% 483
2022
Q4 		$93.6K Hold
1,213
– – 0.02% 411
2022
Q3 		$54K Buy
+1,213
New +$60.6K 0.01% 522

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return